Mitochondrial Metabolism and Hepatic Complications of Obesity
NCT03302481 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2021-08-24
Summary
The study aims to characterize mitochondrial metabolism in the liver of obesity surgery patients and to study its relationships with hepatic steatosis, inflammation, and fibrosis.
Conditions
Interventions
- OTHER
-
liver biopsy
the biopsies will be performed under laparoscopy and taken in the lower part of the right hepatic lobe
Sponsors & Collaborators
-
Nantes University Hospital
lead OTHER
Principal Investigators
-
David JACOBI, Dr · Nantes University Hospital
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-01-31
- Primary Completion
- 2017-01-31
- Completion
- 2017-01-31
More Related Trials
-
Molecular Investigation of Non Alcoholic Fatty Liver Diseases in Obese Patients
NCT00844779 ·Status: UNKNOWN
-
Dynamic Changes and Risk Factors of Fibrosis and Steatosis Progression in Nonalcoholic Fatty Liver Disease
NCT03635541 ·Status: UNKNOWN
-
Non Invasive Measurements of Fibrosis, Inflammation and Steatohepatitis in Morbidly Obese Patients
NCT01695083 ·Status: COMPLETED
-
Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With NAFLD
NCT04774302 ·Status: COMPLETED
-
Non-invasive Diagnostic Model of Liver Fibrosis Associated With NAFLD and Prediction of Prognosis
NCT03842748 ·Status: UNKNOWN
-
Prospective Cohort Study in Patients With NAFLD
NCT00575133 ·Status: RECRUITING
-
Association of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus
NCT01997424 ·Status: COMPLETED ·Phase: NA
-
Identification of Protective and Worsening Steatohepatitis (NASH) Factors
NCT00914446 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of 4 MRI Methods (PDFF 3, 6 and 11 Gradient Echoes and Spectroscopy) Compared to the Reference Method (Liver Biopsy) in Quantification of Hepatic Steatosis
NCT03142698 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Multi-Organ Metabolism and Perfusion in NAFLD by Total Body Dynamic PET Scan on EXPLORER
NCT04165343 ·Status: COMPLETED
-
Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus
NCT04232293 ·Status: COMPLETED ·Phase: NA
-
Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Utilizing Ultrasound and Percutaneous Liver Biopsy
NCT01100398 ·Status: COMPLETED
-
Identification of Biomarkers Related to Liver Fibrosis as New Therapeutic Targets
NCT03979417 ·Status: COMPLETED
-
Observational Cohort of Pancreatic Echo-endoscopy
NCT04226014 ·Status: COMPLETED
-
Impact of FMT on the Phenome in Patients With NAFLD and Fibrosis
NCT06024681 ·Status: COMPLETED ·Phase: NA
-
Impact of Age and BMI on Liver Transplant Outcomes
NCT04853641 ·Status: COMPLETED
-
Combining MRI Steatosis Assessment and Transient Elastography to Improve Liver Fibrosis Diagnosis in Non Alcoholic Fatty Liver Disease
NCT03245606 ·Status: COMPLETED
-
Screening for NAFLD-related Advanced Fibrosis in High Risk Population in Diabetology.
NCT04435054 ·Status: COMPLETED ·Phase: NA
-
Estimation of Steatosis on Liver Transplants by Intraoperative Spectrometry
NCT05106322 ·Status: RECRUITING
-
Liver Fat Quantification by Magnetic Resonance Imaging (MRI) - Prediction of Postoperative Complications
NCT01234714 ·Status: COMPLETED
-
NAFLD Study: US vs Liver Biopsy
NCT04101162 ·Status: UNKNOWN ·Phase: NA
-
Central Obesity and Hepatocellular Carcinoma
NCT03082378 ·Status: UNKNOWN
-
Mapping of Metabolic Liver Functions in Patients With Non-alcoholic Fatty Liver Disease
NCT02488941 ·Status: UNKNOWN
-
Identification of Microbial Properties Predicting a Worsening Course of Fatty Liver Disease
NCT03748511 ·Status: TERMINATED
-
Transoral Endoscopic Liver Biopsy During Laparoscopic Gastric Bypass
NCT00512512 ·Status: COMPLETED